Study expands development of the antibody into hepatocellular carcinoma More: CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment Source: News
read moreThe plummeting demand for Merck’s HPV vaccine Gardasil in China has forced the New Jersey drugmaker to rework its arrangement with its partner in the country, Zhifei Biological Products. More: With Gardasil demand shortfall in China, Merck and Zhifei adjust
read moreHalozyme is putting a recent drug-delivery acquisition to work thanks to a new tie-up with Vertex Pharmaceuticals. More: Vertex taps Halozyme and its recently acquired Elektrofi tech in M drug delivery deal Source: fierce
read moreThe FDA is seeking new powers to hold companies accountable for misleading direct-to-consumer ads, adding legislative weight to its pushback against deceptive drug advertising. More: FDA seeks legislative teeth to bite back against misleading DTC drug ads Source: fierce
read moreIn response to a warning letter from the FDA that accused the company of making “false or misleading” claims about its bladder cancer drug Anktiva, ImmunityBio says it’s implementing enhanced protocols. More: ImmunityBio responds to FDA scrutiny over Anktiva promotional
read moreA recent episode of ABC’s Scrubs featured an on-screen brand integration with Insulet’s Omnipod device worn by beloved TV doctor Christopher Turk. More: Insulet's Omnipod takes Type 2 diabetes representation to the TV screen in 'Scrubs' revival Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals